Advanced Development of a Multivalent Vaccine Candidate for Filovirus and Lassa Fever

Thomas Jefferson University, Philadelphia PA

Investigators

Abstract

To support advanced development of a multivalent vaccine candidates for Filovirus and Lassa Fever. This contract may support formulation and manufacture of the individual vaccine components, as well as stability testing, nonclinical immunogenicity and efficacy testing in nonhuman primates, IND enabling GLP repeated dose toxicology, submission of an IND and eventual clinical evaluation.